A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Clinical trial NCT06012435 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06012435
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-21
- Primary completion
- 2026-05-18
- Enrollment
- 762
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.